Certara launches non-animal navigator™ solution to help drug developers reduce reliance on animal testing

Radnor, pa., april 14, 2025 (globe newswire) -- certara, inc. (nasdaq: cert), a global leader in model-informed drug development, today announced the launch of its non-animal navigator™ solution designed to help biopharmaceutical companies lead the transition ignited by the fda's roadmap to reducing animal testing in preclinical safety studies.
CERT Ratings Summary
CERT Quant Ranking